All Vaccine articles
-
JournalImmunological considerations in the development of novel vaccines
Part 1 of this series explored the elements of the immune response that are important to vaccine effectiveness. Part 2 looks at how understanding of the immune response supports prediction of vaccine effectiveness and can optimise clinical development of vaccines. The article then goes on to look at the impact of population diversity.
-
-
-
JournalImmunological considerations in the development of novel vaccines
This article explores the critical elements of the immune response that contribute to vaccine effectiveness, with reference to the European Medicines Agency’s (EMA) recent scientific guideline on clinical evaluation of new vaccines.
-
-
-
Industry newsBurkina Faso gives R21 malaria vaccine approval in children
Burkina Faso’s regulatory agency – Agence Nationale de la Regulation Pharmaceutique – has approved the R21/Matrix-M malaria vaccine for children.
-
Industry newsHIV-prevention drug is first to be made in South Africa
Indian firm Cipla is first manufacturer approved to produce generic of the HIV-preventer cabotegravir, in South Africa.
-
PodcastsRegRapPod – April 2023
Vol. 20 #4
Our new RegRapPod – the first episode of our podcast series – is available to listen to now. April’s Issue Editor, Vickie Goff discusses Latin America articles with podcast host Alan Booth, who also hears from authors Priti Shah and Anna Litsiou whose article this month is covered in a full interview in a later edition.